To describe a multicentre experience of robot-assisted partial nephrectomy (RAPN) in northern England, with focus on early surgical outcomes and oncological results.
Introduction
Over the past two decades there has been a rise in the detection of small renal masses (SRMs), mainly because of the increasing use of investigative imaging [1] . This has led to a trend towards detecting smaller and often less aggressive renal tumours [2] . Furthermore, there has been a shift towards nephron-sparing techniques for managing SRMs. Evidence is accumulating for the benefits of nephron-sparing surgery compared with radical nephrectomy, including improved long-term morbidity and mortality, better preservation of renal function and similar oncological results [3] [4] [5] . Partial nephrectomy (PN) is the current standard of care for renal tumours <4 cm in size (T1a), and should also be considered for T1b tumours where technically feasible [6] .
Whilst open PN has long been considered the 'gold standard', with excellent long-term functional and oncological outcomes, minimally invasive techniques (laparoscopic and robotic) have increasingly been used for treating renal tumours [7] .
Reported outcomes of laparoscopic PN have suggested similar oncological and functional outcomes to those of open surgery [8, 9] . Robot-assisted PN (RAPN) has overcome some of the challenges of the laparoscopic approach with its shorter learning curve and ease of suturing, and there has been an increase in the adoption of robotic technology and a rise in the number of RAPNs being performed worldwide [10, 11] . Meta-analysis data suggest a lower conversion rate (to either radical nephrectomy or open surgery), shorter warm ischaemia time (WIT) and shorter length of hospital stay for RAPN compared with laparoscopic PN, although complications, operating time and estimated blood loss for both the approaches were similar [12, 13] .
In the UK, the BAUS Nephrectomy Audit in 2012 showed that PNs accounted for 11% of all surgical treatments for renal tumours and that robotic technology was used in 43.9% of all PNs performed for T1a tumours [14] . RAPN in the UK is currently being delivered mostly in tertiary referral centres and experience is accumulating [15] . Furthermore, analysis of the BAUS nephrectomy database reported that 55% of PNs were performed using minimally invasive techniques in 2014 [16] . These data also suggest that centres in the UK undertaking minimally invasive PN perform 25-35 cases per year on average. Reports describing outcomes of RAPN in the UK are lacking and, with many centres being in the early learning curve phase for the procedure, it is important to investigate if early results match previously published international data. In the present study we therefore set out to describe a multi-centre experience of RAPN in northern England, with focus on early outcomes and oncological results.
Methods
All patients undergoing RAPN at four institutions across northern England in the period October 2012 and December 2015 were included for analysis. Patients were selected for RAPN after local multidisciplinary team review, and factors considered included tumour size and complexity, medical comorbidity, renal function and patient preference. RAPN represented a transition from laparoscopic PN in three of the four institutions and was therefore being undertaken by experienced urological surgeons. In addition, four out of the five surgeons had extensive pelvic robotic surgery experience before they initiated the RAPN service.
Surgical Technique
RAPN was performed as previously described via a transperitoneal approach [11, 17] . Patients were placed in the lateral position. The four-arm daVinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) was used. A medial trocar configuration was used with the camera located medially near the umbilicus and two robotic ports placed along the mid-clavicular line (1~2 cm below the costal margin and the other in the iliac region). An assistant port was placed medially cranial (or caudal) to the camera port, and for rightsided procedures, a 5-mm epigastric port was used for liver retraction where required. The fourth robotic arm was used according to surgeon preference. Dissection allowed identification of the hilar vascular anatomy and tumourbearing area of the kidney (intra-operative ultrasonography was used in some centres to aid tumour localization) [18] . After dissection and identification of the hilum, a sling was applied to the renal arteries which were clamped using the Scanlan robotic bulldog clamp â (Scanlan International, St. Paul, MN, USA). Tumour excision was carried out sharply using the robotic scissors. Bleeding vessels in the excised tumour bed were oversewn using 2-0 polyglactin sutures with LapraTy (Ethicon, Cincinnati, OH, USA) clips. If the collecting system was opened, over-sewing was again performed using a polyglactin suture. The use of Surgicel (Ethicon, Kirkton, UK) bolsters and tissue sealants (e.g. Floseal; Baxter Healthcare, Newbury, UK) was according to surgeon preference. Renal reconstruction with sliding clip renorrhaphy using polyglactin sutures and Weck Hem-O-Lock clips (Teleflex, Research Triangle Park, NC, USA) was performed as previously described [19] .
Data Collection and Analysis
Peri-operative data were collected prospectively to identify demographic details, tumour and imaging characteristics (size, location, R.E.N.A.L. nephrometry score), peri-operative characteristics (operating console time, blood loss, WIT), postoperative course (length of hospital stay, complications) and pathological characteristics (tumour histology, margin status) [20] . Renal function was assessed by creatinine level and estimated GFR (eGFR) calculated using the Modification of Diet in Renal Disease formula.
Student's t test was used to compare the means of preoperative and postoperative eGFR. Univariate analysis was used to test the association between positive surgical margin (PSM) status and learning curve, tumour location, R.E.N.A.L. nephrometry score, tumour size and histology. To study the learning curve effect we defined 'early learning curve' as the first 100 cases performed in the series (first 25 from each centre) and 'late learning curve' as the last 100 cases in the series. Pearson's correlation coefficient was used to investigate the relationship between rising R.E.N.A.L. nephrometry score and WIT. Statistical analyses were performed using SPSS software (SPSS Inc, Chicago, IL, USA). A P value < 0.05 was taken to indicate statistical significance.
Results

Demographic and Tumour Characteristics
A total of 250 patients were included for analysis ( Table 1 ). The mean AE SD age was 58.1 AE 13 years, the mean AE SD BMI was 27.3 AE 7 kg/m 2 and the median American Society of Anesthesiologists score was 2, with a men to women ratio of 1.3:1. The mean mean AE SD tumour size was 30.6 AE 10 mm, 55% of tumours were leftsided and location was upper, mid and lower pole in 27.6%, 21.6% and 50.8% of patients, respectively. The median R.E.N.A.L. nephrometry score was 6, and 38.2% were classified as medium or highly complex tumours (R.E.N.A.L. score ≥7). 18% of tumours were > 4 cm. With increasing experience, more complex tumours were being tackled, as highlighted by a shift towards a higher R.E.N.A.L. nephrometry score over the study period (median R.E.N.A.L. nephrometry score of 8 for the last 50 cases compared with a score of 5 for the first 50 cases). RAPN accounted for 78% of all nephron-sparing surgical procedures at our centres during the study period.
Peri-Operative and Biochemical Characteristics
The mean AE SD operating console time was 141 AE 38 min and the mean WIT was 16.7 AE 8 min. There were five conversions (2%) to open/radical nephrectomy. The median (range) estimated blood loss was 100 (30-1500) mL. The median (range) length of hospital stay was 3 (1-25) days. The preoperative distribution of chronic kidney disease (CKD) was 53.4%, 36.2% and 10.4% for stages 1, 2 and 3, respectively. Postoperatively, the CKD distribution was 34.9% for stage 1, 43.6% for stage 2, 19.6% for stage 3 and 1.9% for stage 4. The mean preoperative and immediate postoperative eGFR was 92.8 AE 27 vs 80.8 AE 27 mL/min/ 1.73 m 2 (P = 0.001). The mean eGFR change after RAPN was À12.2 AE 17, but 66% of patients remained in the same CKD category and none of the patients required dialysis during the study period.
Pathological Analysis
82.4% of tumours were malignant, with clear-cell RCC being the most common (62.8%), 10.8% of tumours were oncocytomas (Table 2 ) and 1.4% of tumours were stage pT3a as a result of microscopic fat invasion. There were 18 PSMs in 246 patients (as four cases were converted to radical nephrectomy), giving an overall PSM rate of 7.3%.
Complications and Follow-Up
The overall complication rate was 16.4% with Clavien I (1.6%), Clavien II (8.8%) and Clavien III (6%). There were no Clavien IV or V complications. The transfusion rate was 4.8%, the angio-embolization rate for postoperative bleeding was 2.4% and the urine leak rate was 2%.The median (range) follow-up was 12 (3-36) months and there was one local recurrence (0.4%) involving a patient with a cystic RCC, which burst intra-operatively during excision causing spillage; that patient presented at 3 months with malignant ascites.
Clinicopathological Correlations
'Trifecta' (defined as WIT <25 min, negative surgical margin status and no peri-operative complications) was achieved in 68.4% of all cases [21] . Trifecta was observed in 66% of cases in the early learning curve experience compared with 75% in the late learning curve. The trifecta rate improved further when considering the last 50 cases of the series (82%, On univariate analysis, PSM status was significantly associated with early learning curve (P = 0.031) and upper pole location (P = 0.043), but not with R.E.N.A.L. nephrometry score (P = 0.75) or tumour size (P = 0.22). WIT was statistically longer during the early learning curve compared with later experience (19.5 AE 9 vs 17.2 AE 5.9; P = 0.04). WIT of >25 min was not significantly associated with complication rate (P = 0.92) or PSM status (P = 0.39). There was also no correlation observed between rising R.E.N.A.L. nephrometry score and WIT (Pearson's r = À0.09; P = 0.18).
Complication rates did not increase between the early and late learning curve (15 vs 16%) and the median nephrometry score was 6 during both periods. When considering only the last 50 cases, the overall complication rate was 8%, with a median tumour nephrometry score of 8, indicating an increase in tumour complexity towards the end of the study period. Table 3 summarizes the key clinicopathological correlations between the early and late learning curve.
Discussion
We present data from the largest multicentre UK study on RAPN to date. We confirm the feasibility and safety of this technique for treating renal tumours in this multicentre study. Achievement of trifecta was 68.4%, the PSM rate was 7.3% and the major complication rate (Clavien ≥3) was 6%. In terms of early functional outcomes, two-thirds of patients remained in the same CKD category with none requiring dialysis (just less than 50% of the study population had preexisting CKD stage 2 and 3). It should be noted that it is not routine policy to biopsy SRMs prior to RPN at all of the centres included in this study. Only 4% of patients in the study group underwent percutaneous renal biopsy before surgery. Because of the high diagnostic accuracy of abdominal imaging, renal tumour biopsy is not necessary in patients with a contrast-enhancing renal mass for whom surgery is planned, as highlighted in the European Association of Urology guidelines. There is however an increasing role for percutaneous biopsy for SRMs for which active surveillance is pursued or before ablative and systemic therapy without previous pathology [22, 23] .
Achievement of the trifecta has been used as benchmark for RAPN efficacy in the literature. Despite increasing tumour complexity, trifecta outcomes of minimally invasive PN have improved significantly in the last decade, leading authors to suggest that the trifecta should be a routine goal during PN [21] . In a recent multicentre US series of >1 185 RPNs, a trifecta rate for RPN of 70% was reported when performed by surgeons with significant expertise with the technique [24] .
We noted an improvement in trifecta rates over the study period, in keeping with the learning curve effect for RAPN. It is to be noted that surgeons performing RAPN at the different centres in the present study were experienced with laparoscopic PN and this could explain the relatively high trifecta rate even in the early learning curve.
The impact of PSM status at RAPN on long-term survival outcomes is unclear, but local/regional recurrence is a concern [25] . Yossepowitch et al. [26] described 1 390 PNs (PSM rate 5.5%) and showed no increase in the risk of local recurrence or metastatic disease in patients with PSMs. They found that the overall 10-year probability of freedom from local disease recurrence and metastatic progression was 93%, with no significant difference between patients with positive and negative margins. Shah et al. [27] , however, reported that PSMs after PN increase the risk of disease recurrence, primarily in patients with adverse pathological features (pT2-3a or Fuhrman grades III-IV). They studied 1 240 patients (median follow-up 33 months) undergoing PN, and found a 7.8% PSM rate and a 5.6% regional recurrence rate. PSM status was associated with an increased risk of relapse on multivariable analysis and was significantly associated with a higher risk of recurrence in cases considered high risk [27] . PSMs in early reported RAPN series occur in up to 7.7% of cases [28] [29] [30] . More recently, results from centres with accumulated experience have reported PSM rates between 1.7 and 3.2% [24, 31, 32] . Our PSM rate in the early learning curve was 11%, but was reduced to 2% towards the end of the study period and is in keeping with published reports.
Macroscopic inspection alone and frozen section assessment of margins at PN cannot reliably predict the final pathological margin status [33, 34] . As such, adjunctive techniques have been developed to reduce PSMs during RAPN, including intra-operative ultrasonography and intra-operative fluorescence imaging. There is accumulating evidence that intra-operative ultrasonography can help quality control of margins at the time of PN, although a learning curve is also associated with the use of ultrasonography [18, 35] . The majority of our centres adopted intra-operative ultrasonography throughout the study period. Near-infrared fluorescence imaging with intra-operative administration of indocyanine green (ICG) is not currently employed at our centres. ICG is a water-soluble dye that fluoresces bright green when viewed under near-infrared light (700-1 000 nm). In RAPN, this technology potentially allows the differentiation of renal tumour from normal parenchyma, thereby aiding tumour excision. Furthermore, near-infrared fluorescence imaging with ICG has been used to facilitate selective arterial clamping, allowing a regional perfusion deficit in the kidney to be readily identified and therefore targeted at a given tumour [36] .
Partial nephrectomy has been shown to be effective in the preservation of renal function [7, 37] . Decline in function after PN averages~20% in the operated kidney, and can be attributable to incomplete recovery from the ischaemic insult or loss of nephron mass related to parenchymal excision or collateral damage during reconstruction [38] . A recent study of >350 patients undergoing minimally invasive PN followed up for a median time of 39 months showed that 13% of patients had CKD class progression, with estimates for remaining free of CKD class progression at 5, 7 and 10 years being 86.98%, 75.45% and 53.54%, respectively [39] . The authors also noted that lower preoperative eGFR, larger tumour size and longer ischaemia time were associated with CKD class progression. Andrade et al. [31] reported 5-year functional outcomes of RAPN and showed a 19.1% chronic kidney disease upstaging rate. In the present study, we found a higher rate (33%) of CKD upstaging, but this related to immediate postoperative eGFR and almost half of our study population were already in CKD stages 2 and 3. Although the average loss of eGFR immediately after surgery was 12.2 mL/ min/1.73 m 2 , none of the patients required dialysis during the study period. Our study follow-up was, however, relatively short and we were not able to capture medium to long-term changes in eGFR.
Clavien 1-2 complications after RAPN have been reported in 10-37% of patients and Clavien 3-5 complications in 2.47-11.1% [13, 40, 41] . Meta-analysis data comparing minimally invasive PN techniques have shown that RAPN had a significantly lower rate of conversion to open (or radical) surgery [13] . One of the largest reported RAPN series (1 185 RAPNs) reported an overall complication rate of 16.2% [31] . Our data compare well with published series, with an overall complication rate of 16.4% (with a Clavien 3-4 complication rate of 6% and conversion to open/radical surgery rate of 2%). There was no correlation between complication rate and tumour complexity. We nevertheless identified one early recurrence with a tumour spillage from rupture of a cystic tumour during excision; in the early learning curve these cases should be tackled with care or not performed using RAPN.
In summary, the present multicentre contemporary report shows what can be achieved in a real-life setting in northern England. It should be noted that each individual centre performs fewer than 50 RAPN cases per year but, with the correct expertise, outcomes compare well with the large published single-centre series. In conclusion, this was the largest multicentre RAPN study in the UK. Initial results show that RAPN is safe and can be performed with minimal morbidity. Early oncological outcomes and renal function preservation data were encouraging.
